Else Marie Agger

9.1k citations

97 papers · 7.9k · 1 hit paper · h-index 49

Impact in

Infectious Diseases top 0.5%
- Tuberculosis Research and Epidemiology
Immunology top 0.5%
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
- Immune responses and vaccinations
- T-cell and B-cell Immunology

Papers in

Infectious Diseases 58
- Tuberculosis Research and Epidemiology 58
Immunology 37
- Immunotherapy and Immune Responses 36
- Immune Response and Inflammation 3

Co-authors: Peter Lawætz Andersen (83 shared papers)Dennis Christensen (27 shared papers)Ida Rosenkrands (22 shared papers)Karen Smith Korsholm (12 shared papers)Thomas Lindenstrøm (16 shared papers)Claus Aagaard (13 shared papers)Yvonne Perrie (13 shared papers)Laurens A.H. van Pinxteren (3 shared papers)
Journals: PLoS ONE (13 papers)The Journal of Immunology (10 papers)Vaccine (9 papers)Infection and Immunity (5 papers)Scientific Reports (4 papers)
Partner nations: Denmark United Kingdom United States

In The Last Decade

Else Marie Agger

97 papers receiving 7.8k citations

Else Marie Agger's Hit Papers

align trajectories log scale

The Vaccine Adjuvant Chitosan Promotes Cellular Immunity via DNA Sensor cGAS-STING-Dependent Induction of Type I Interferons 2016 · 542 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2016 Immunity

Peers

Countries citing papers authored by Else Marie Agger

Since Specialization

Citations

This map shows the geographic impact of Else Marie Agger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Else Marie Agger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Else Marie Agger more than expected).

Fields of papers citing papers by Else Marie Agger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Else Marie Agger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Else Marie Agger. The network helps show where Else Marie Agger may publish in the future.

Co-authors

The 25 scholars most cited alongside Else Marie Agger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Else Marie Agger Line = papers co-authored together Else Marie Agger links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 97 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The Vaccine Adjuvant Chitosan Promotes Cellular Immunity via DNA Sensor cGAS-STING-Dependent Induction of Type I Interferons Immunity ·Elizabeth C. Carroll, Lei Jin, Andrés Mori, Natalia Muñoz‐Wolf, Ewa Oleszycka, Hannah B.T. Moran, Samira Mansouri, Craig P. McEntee Hit paper breakdown →	2016	542
2	Cutting Edge: Mincle Is Essential for Recognition and Adjuvanticity of the Mycobacterial Cord Factor and its Synthetic Analog Trehalose-Dibehenate The Journal of Immunology ·Hanne Schoenen, Barbara Bodendorfer, Kelly Hitchens, Silvia Manzanero, Kerstin Werninghaus, Falk Nimmerjahn, Else Marie Agger, Steffen Stenger	2010	420
3	Tuberculosis Subunit Vaccination Provides Long-Term Protective Immunity Characterized by Multifunctional CD4 Memory T Cells The Journal of Immunology ·Thomas Lindenstrøm, Else Marie Agger, Karen Smith Korsholm, Patricia A. Darrah, Claus Aagaard, Robert A. Seder, Ida Rosenkrands, Peter Lawætz Andersen	2009	365
4	Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells European Journal of Immunology ·Laurens A.H. van Pinxteren, Joseph P. Cassidy, Birgitte H. C. Smedegaard, Else Marie Agger, Peter Lawætz Andersen	2000	312
5	Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6′-dibehenate)—A novel adjuvant inducing both strong CMI and antibody responses Biochimica et Biophysica Acta (BBA) - Biomembranes ·Jesper Rømhild Davidsen, Ida Rosenkrands, Dennis Christensen, A. Vangala, Daniel J. Kirby, Yvonne Perrie, Else Marie Agger, Peter Lawætz Andersen	2005	308
6	Diagnosis of Tuberculosis Based on the Two Specific Antigens ESAT-6 and CFP10 Clinical and Diagnostic Laboratory Immunology ·Laurens A.H. van Pinxteren, Pernille Ravn, Else Marie Agger, John M. Pollock, Peter Lawætz Andersen	2000	283
7	Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRγ–Syk–Card9–dependent innate immune activation The Journal of Experimental Medicine ·Kerstin Werninghaus, Anna Babiak, Olaf Groß, Christoph Hölscher, Harald Dietrich, Else Marie Agger, Jörg Mages, Attila Mócsai	2009	280
8	Cationic Liposomes Formulated with Synthetic Mycobacterial Cordfactor (CAF01): A Versatile Adjuvant for Vaccines with Different Immunological Requirements PLoS ONE ·Else Marie Agger, Ida Rosenkrands, Jon Ulf Hansen, Karima Brahimi, Brian Vandahl, Claus Aagaard, Kerstin Werninghaus, Carsten J. Kirschning	2008	252
9	A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human Vaccine ·Jaap T. van Dissel, Simone A. Joosten, Soren Tetens Hoff, Darius Soonawala, Corine Prins, David A. Hokey, Dawn M. O’Dee, Andrew J. Graves	2014	213
10	Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6 Vaccine ·Jan A. M. Langermans, Timothy Mark Doherty, Richard A. W. Vervenne, Tridia van der Laan, Konstantin P. Lyashchenko, Rena Greenwald, Else Marie Agger, Claus Aagaard	2004	212
11	Cationic liposomes as vaccine adjuvants Expert Review of Vaccines ·Dennis Christensen, Karen Smith Korsholm, Peter Lawætz Andersen, Else Marie Agger	2011	206
12	Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens Scientific Reports ·Niels Peter Hell Knudsen, Anja Weinreich Olsen, Cecilia Buonsanti, Frank Follmann, Yuan Zhang, Rhea N. Coler, Christopher B. Fox, Andreas L. Meinke	2016	198
13	The adjuvant mechanism of cationic dimethyldioctadecylammonium liposomes Immunology ·Karen Smith Korsholm, Else Marie Agger, Camilla Foged, Dennis Christensen, Jes Dietrich, Claire Swetman Andersen, Carsten Geisler, Peter Lawætz Andersen	2007	168
14	Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response Journal of Controlled Release ·Malou Henriksen‐Lacey, Dennis Christensen, Vincent W. Bramwell, Thomas Lindenstrøm, Else Marie Agger, Peter Lawætz Andersen, Yvonne Perrie	2010	152
15	Control of Chronic Mycobacterium tuberculosis Infection by CD4 KLRG1− IL-2–Secreting Central Memory Cells The Journal of Immunology ·Thomas Lindenstrøm, Niels Peter Hell Knudsen, Else Marie Agger, Peter Lawætz Andersen	2013	145
16	The Mincle-Activating Adjuvant TDB Induces MyD88-Dependent Th1 and Th17 Responses through IL-1R Signaling PLoS ONE ·Christiane Desel, Kerstin Werninghaus, Manuel Ritter, Katrin Jozefowski, Norman F. Russkamp, Ulrike Schleicher, Dennis Christensen, Stefan J. Wirtz	2013	132
17	Cationic liposomes as vaccine adjuvants Expert Review of Vaccines ·Dennis Christensen, Karen Smith Korsholm, Ida Rosenkrands, Thomas Lindenstrøm, Peter Lawætz Andersen, Else Marie Agger	2007	122
18	Vaccine-Induced Th17 Cells Are Maintained Long-Term Postvaccination as a Distinct and Phenotypically Stable Memory Subset Infection and Immunity ·Thomas Lindenstrøm, Joshua S. Woodworth, Jes Dietrich, Claus Aagaard, Peter Lawætz Andersen, Else Marie Agger	2012	115
19	Protective immunity to tuberculosis with Ag85B-ESAT-6 in a synthetic cationic adjuvant system IC31 Vaccine ·Else Marie Agger, Ida Rosenkrands, Anja Weinreich Olsen, Graham J. Hatch, Ann Williams, Constantia E. Kritsch, Karen Lingnau, Alexander von Gabain	2006	109
20	A cationic vaccine adjuvant based on a saturated quaternary ammonium lipid have different in vivo distribution kinetics and display a distinct CD4 T cell-inducing capacity compared to its unsaturated analog Journal of Controlled Release ·Dennis Christensen, Malou Henriksen‐Lacey, Arun T. Kamath, Thomas Lindenstrøm, Karen Smith Korsholm, Jan Pravsgaard Christensen, Anne‐Françoise Rochat, Paul‐Henri Lambert	2012	103

About Else Marie Agger

Else Marie Agger is a scholar working on Infectious Diseases, Immunology, Pharmaceutical Science, Virology and Hepatology, having authored 97 papers that have together received 7.9k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (58 papers), Immunotherapy and Immune Responses (36 papers), Advanced Drug Delivery Systems (5 papers), Advancements in Transdermal Drug Delivery (3 papers), Immune Response and Inflammation (3 papers), Nanoparticle-Based Drug Delivery (2 papers), HIV Research and Treatment (2 papers) and Influenza Virus Research Studies (2 papers). The work is most often cited by research in Infectious Diseases (3.3k citations), Immunology (3.1k citations), Pharmaceutical Science (604 citations), Biomaterials (551 citations) and Microbiology (240 citations). Else Marie Agger has collaborated with scholars based in Denmark, United Kingdom and United States. Frequent co-authors include Peter Lawætz Andersen, Dennis Christensen, Ida Rosenkrands, Karen Smith Korsholm, Thomas Lindenstrøm, Claus Aagaard, Yvonne Perrie, Laurens A.H. van Pinxteren, Camilla Foged and Joseph P. Cassidy. Their work appears in journals such as PLoS ONE, The Journal of Immunology, Vaccine, Infection and Immunity and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Else Marie Agger

Impact in

Papers in i

In The Last Decade

Else Marie Agger

Else Marie Agger's Hit Papers

Peers

Countries citing papers authored by Else Marie Agger

Fields of papers citing papers by Else Marie Agger

All Works

About Else Marie Agger

Explore authors with similar magnitude of impact

Papers in